Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.7 USD | 0.00% | +0.59% | +1.80% |
Business Summary
Number of employees: 47
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cardiovascular Medicines
100.0
%
| 5 | 100.0 % | 1 | 100.0 % | -80.00% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 5 | 100.0 % | 1 | 100.0 % | -80.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Oliveto
CEO | Chief Executive Officer | 56 | 17-03-06 |
Amit Hasija
DFI | Director of Finance/CFO | 51 | 19-09-08 |
Anita Holz
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-31 |
Chief Tech/Sci/R&D Officer | - | 21-10-31 | |
David Bharucha
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-02-14 |
Jeff Nelson
COO | Chief Operating Officer | 42 | 20-05-31 |
Kimberly Sheehan
HRO | Human Resources Officer | - | 22-03-31 |
Roshan Girglani
SAM | Sales & Marketing | - | 22-07-31 |
Lorenz Muller
PRN | Corporate Officer/Principal | 60 | 17-09-30 |
Guy Rousseau
LAW | General Counsel | - | 15-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Seth Fischer
BRD | Director/Board Member | 68 | 23-03-20 |
Joseph Oliveto
CEO | Chief Executive Officer | 56 | 17-03-06 |
Debra Liebert
BRD | Director/Board Member | 67 | 15-05-31 |
Director/Board Member | 75 | 19-11-10 | |
Michael Tomsicek
BRD | Director/Board Member | 58 | 19-03-31 |
Lisa Giles
BRD | Director/Board Member | 65 | 20-09-30 |
Robert Wills
CHM | Chairman | 70 | 20-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 53,149,778 | 52,815,928 ( 99.37 %) | 0 | 99.37 % |
Company contact information
Milestone Pharmaceuticals, Inc.
1111 Dr. Frederik-Philips Boulevard Suite 420
H4M 2X6, Montréal
+
http://www.milestonepharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.80% | 107M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- MIST Stock
- Company Milestone Pharmaceuticals Inc.